Davenport & CO LLC Nex Immune, Inc. Transaction History

Davenport & CO LLC

  • $16 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 20, 2023
BUY
$0.26 - $0.47 $2,080 - $3,760
8,000 Added 44.44%
26,000 $7,000
Q1 2023

Apr 27, 2023
BUY
$0.3 - $0.6 $2,250 - $4,500
7,500 Added 71.43%
18,000 $6,000
Q3 2022

Oct 11, 2022
BUY
$0.6 - $17.5 $6,300 - $183,750
10,500 New
10,500 $6,000

About NexImmune, Inc.

NEXI Quotes by TradingView
  • Ticker NEXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,155,600
  • Market Cap $7.25M
  • Description
  • NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...
More about NEXI
Track This Portfolio

Track Davenport & CO LLC Portfolio

Follow Davenport & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email